Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

491 public trials 153 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Completed

Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

NCT03201458

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 41 locations
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

NCT04676633

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Atlantic Health System Morristown, New Jersey, United States
View Trial Details
Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

NCT03339843

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +32 more
Locations
  • Universitair Ziekenhuis Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Algemeen Ziekenhuis Groeninge Kortrijk, Belgium
  • CHC Saint-Joseph Liège, Belgium
View Trial Details
Completed

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285

Conditions
Adenocarcinoma, Advanced or Metastatic Solid Tumors, Breast Cancer, +45 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Laura and Isaac Perlmutter Cancer Center New York, United States
View Trial Details
Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

NCT03219268

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +48 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 40 locations
View Trial Details
Completed

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

NCT03230318

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 41 locations
View Trial Details

Related conditions